473 related articles for article (PubMed ID: 7812973)
21. Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents.
Itzhak Y
Mol Pharmacol; 1989 Oct; 36(4):512-7. PubMed ID: 2554109
[TBL] [Abstract][Full Text] [Related]
22. [Characteristics and regulation of 3H-haloperidol binding to rat brain sigma receptors].
Kizu A
Yakubutsu Seishin Kodo; 1991 Apr; 11(2):129-39. PubMed ID: 1656649
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor.
Wu XZ; Bell JA; Spivak CE; London ED; Su TP
J Pharmacol Exp Ther; 1991 Apr; 257(1):351-9. PubMed ID: 1850471
[TBL] [Abstract][Full Text] [Related]
24. Modulation of (+)-[3H]pentazocine binding to guinea pig cerebellum by divalent cations.
Basile AS; Paul IA; Mirchevich A; Kuijpers G; De Costa B
Mol Pharmacol; 1992 Nov; 42(5):882-9. PubMed ID: 1279378
[TBL] [Abstract][Full Text] [Related]
25. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
Sircar R; Nichtenhauser R; Ieni JR; Zukin SR
J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795
[TBL] [Abstract][Full Text] [Related]
26. Sigma receptors are associated with cortical limbic areas in the primate brain.
Mash DC; Zabetian CP
Synapse; 1992 Nov; 12(3):195-205. PubMed ID: 1481139
[TBL] [Abstract][Full Text] [Related]
27. Sigma receptors in post-mortem human brains.
Weissman AD; Su TP; Hedreen JC; London ED
J Pharmacol Exp Ther; 1988 Oct; 247(1):29-33. PubMed ID: 2845055
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment.
Kovács KJ; Larson AA
Eur J Pharmacol; 1998 May; 350(1):47-52. PubMed ID: 9683013
[TBL] [Abstract][Full Text] [Related]
29. [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe.
Xu J; Tu Z; Jones LA; Vangveravong S; Wheeler KT; Mach RH
Eur J Pharmacol; 2005 Nov; 525(1-3):8-17. PubMed ID: 16289030
[TBL] [Abstract][Full Text] [Related]
30. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein.
Maletínská L; Blakely EA; Bjornstad KA; Deen DF; Knoff LJ; Forte TM
Cancer Res; 2000 Apr; 60(8):2300-3. PubMed ID: 10786698
[TBL] [Abstract][Full Text] [Related]
31. Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand.
Campa MJ; Schreiber G; Bepler G; Bishop MJ; McNutt RW; Chang KJ; Patz EF
Cancer Res; 1996 Apr; 56(7):1695-701. PubMed ID: 8603422
[TBL] [Abstract][Full Text] [Related]
32. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
33. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
Nguyen VH; Kassiou M; Johnston GA; Christie MJ
Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
[TBL] [Abstract][Full Text] [Related]
34. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
[TBL] [Abstract][Full Text] [Related]
35. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line.
Ganapathy ME; Prasad PD; Huang W; Seth P; Leibach FH; Ganapathy V
J Pharmacol Exp Ther; 1999 Apr; 289(1):251-60. PubMed ID: 10087012
[TBL] [Abstract][Full Text] [Related]
36. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
37. Multiple [3H]DTG binding sites in guinea pig cerebellum: evidence for the presence of non-specific binding.
Basile AS; DeCosta B; Paul IA
Eur J Pharmacol; 1994 Feb; 252(2):139-46. PubMed ID: 8157054
[TBL] [Abstract][Full Text] [Related]
38. The presence of sigma-receptors in the lacrimal gland.
Schoenwald RD; Barfknecht CF; Xia E; Newton RE
J Ocul Pharmacol; 1993; 9(2):125-39. PubMed ID: 8345285
[TBL] [Abstract][Full Text] [Related]
39. [3H]DuP 734 [1-(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'- oxoethyl)-piperidine HBr]: a receptor binding profile of a high-affinity novel sigma receptor ligand in guinea pig brain.
Culp SG; Rominger D; Tam SW; De Souza EB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1175-87. PubMed ID: 1361573
[TBL] [Abstract][Full Text] [Related]
40. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain.
Harada Y; Hara H; Sukamoto T
Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
